Sundrug Co.,Ltd. (TYO: 9989)
Japan
· Delayed Price · Currency is JPY
4,116.00
+15.00 (0.37%)
Jan 20, 2025, 3:30 PM JST
Sundrug Co.,Ltd. Revenue
Sundrug Co.,Ltd. had revenue of 201.02B JPY in the quarter ending September 30, 2024, with 6.05% growth. This brings the company's revenue in the last twelve months to 775.66B, up 7.29% year-over-year. In the fiscal year ending March 31, 2024, Sundrug Co.,Ltd. had annual revenue of 751.78B with 8.88% growth.
Revenue (ttm)
775.66B
Revenue Growth
+7.29%
P/S Ratio
0.62
Revenue / Employee
116.43M
Employees
6,662
Market Cap
481.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
Mar 31, 2021 | 634.31B | 16.54B | 2.68% |
Mar 31, 2020 | 617.77B | 29.70B | 5.05% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |